Biocryst Pharmaceuticals (BCRX) Price to Sales (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) Price to Sales came in at 2.71 for Q2 2026, down 19.6% from 3.37 a year earlier and down 0.6% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Biocryst Pharmaceuticals' Price to Sales stood at 1.90, down 45.4% from FY2024.
- Annual Price to Sales has declined for five consecutive years.
- In prior years, Biocryst Pharmaceuticals' Price to Sales was 3.48 in FY2024 (-6.4%), 3.72 in FY2023 (-53.3%), 7.97 in FY2022 (-51.0%) and 16.25 in FY2021 (-78.0%).
- Quarterly Price to Sales has run from a low of 1.90 in Q4 2025 to a high of 22.66 in Q3 2021 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last four quarters, with an average decline of 14.6% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2021, with growth of 338.3%; the weakest was Q4 2021, with a decline of 78.0%.
- According to Business Quant data, Price to Sales for the three prior quarters was 2.73 (Q1 2026), 1.90 (Q4 2025) and 2.66 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 |
| Mar 31, 2026 | 2.73 |
| Dec 31, 2025 | 1.90 |
| Sep 30, 2025 | 2.66 |
| Jun 30, 2025 | 3.37 |
| Mar 31, 2025 | 3.12 |
| Dec 31, 2024 | 3.48 |
| Sep 30, 2024 | 3.82 |
| Jun 30, 2024 | 3.34 |
| Mar 31, 2024 | 2.95 |
| Dec 31, 2023 | 3.72 |
| Sep 30, 2023 | 4.23 |
| Jun 30, 2023 | 4.35 |
| Mar 31, 2023 | 5.44 |
| Dec 31, 2022 | 7.97 |
| Sep 30, 2022 | 9.85 |
| Jun 30, 2022 | 9.66 |
| Mar 31, 2022 | 16.05 |
| Dec 31, 2021 | 16.25 |
| Sep 30, 2021 | 22.66 |
API Access
Biocryst Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();